New Drug Gives Hope to Those with Advanced Prostate Cancer


By Molly Clifton

The Food and Drug Administration has approved a new drug to treat men with advanced prostate cancer that has spread to the bone.

Xofigo binds with minerals in the bone to deliver radiation to tumors and limits damage to surrounding tissues.

Research shows people who took the drug lived about 3 months longer than those who took placebo.


This content requires the latest Adobe Flash Player and a browser with JavaScript enabled. Click here for a free download of the latest Adobe Flash Player.

What's onFull Schedule

Hot Video From AP

AP Video